These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 16137657

  • 1. Intronic UGG repeats coordinate splicing of CD44 alternative exons v8 and v9.
    Galiana-Arnoux D, Del Gatto-Konczak F, Gesnel MC, Breathnach R.
    Biochem Biophys Res Commun; 2005 Oct 21; 336(2):667-73. PubMed ID: 16137657
    [Abstract] [Full Text] [Related]

  • 2. Molecular mechanisms regulating the tumor-targeting potential of splice-activated gene expression.
    Hayes GM, Dougherty ST, Davis PD, Dougherty GJ.
    Cancer Gene Ther; 2004 Dec 21; 11(12):797-807. PubMed ID: 15359288
    [Abstract] [Full Text] [Related]

  • 3. Restricted patterns of CD44 variant exon expression in human papillary thyroid carcinoma.
    Ermak G, Jennings T, Robinson L, Ross JS, Figge J.
    Cancer Res; 1996 Mar 01; 56(5):1037-42. PubMed ID: 8640758
    [Abstract] [Full Text] [Related]

  • 4. Alternative splicing as a novel of means of regulating the expression of therapeutic genes.
    Hayes GM, Carpenito C, Davis PD, Dougherty ST, Dirks JF, Dougherty GJ.
    Cancer Gene Ther; 2002 Feb 01; 9(2):133-41. PubMed ID: 11857030
    [Abstract] [Full Text] [Related]

  • 5. The CD44 alternative v9 exon contains a splicing enhancer responsive to the SR proteins 9G8, ASF/SF2, and SRp20.
    Galiana-Arnoux D, Lejeune F, Gesnel MC, Stevenin J, Breathnach R, Del Gatto-Konczak F.
    J Biol Chem; 2003 Aug 29; 278(35):32943-53. PubMed ID: 12826680
    [Abstract] [Full Text] [Related]

  • 6. Identification of novel splice variants of the human CD44 gene.
    Vela E, Roca X, Isamat M.
    Biochem Biophys Res Commun; 2006 Apr 28; 343(1):167-70. PubMed ID: 16530165
    [Abstract] [Full Text] [Related]

  • 7. The emergence of alternative 3' and 5' splice site exons from constitutive exons.
    Koren E, Lev-Maor G, Ast G.
    PLoS Comput Biol; 2007 May 28; 3(5):e95. PubMed ID: 17530917
    [Abstract] [Full Text] [Related]

  • 8. Heparan sulfate composition of alternatively spliced CD44 fusion proteins.
    Piepkorn M, Hovingh P, Bennett KL, Linker A.
    Biochem Biophys Res Commun; 1999 Apr 21; 257(3):839-42. PubMed ID: 10208870
    [Abstract] [Full Text] [Related]

  • 9. Alternative splicing of fibronectin mRNAs in chondrosarcoma cells: role of far upstream intron sequences.
    Flanagan M, Liang H, Norton PA.
    J Cell Biochem; 2003 Nov 01; 90(4):709-18. PubMed ID: 14587027
    [Abstract] [Full Text] [Related]

  • 10. A strong exonic splicing enhancer in dystrophin exon 19 achieve proper splicing without an upstream polypyrimidine tract.
    Habara Y, Doshita M, Hirozawa S, Yokono Y, Yagi M, Takeshima Y, Matsuo M.
    J Biochem; 2008 Mar 01; 143(3):303-10. PubMed ID: 18039686
    [Abstract] [Full Text] [Related]

  • 11. Correction of aberrant FGFR1 alternative RNA splicing through targeting of intronic regulatory elements.
    Bruno IG, Jin W, Cote GJ.
    Hum Mol Genet; 2004 Oct 15; 13(20):2409-20. PubMed ID: 15333583
    [Abstract] [Full Text] [Related]

  • 12. Evidence for the regulation of alternative splicing via complementary DNA sequence repeats.
    Lian Y, Garner HR.
    Bioinformatics; 2005 Apr 15; 21(8):1358-64. PubMed ID: 15673565
    [Abstract] [Full Text] [Related]

  • 13. hnRNP L inhibits CD44 V10 exon splicing through interacting with its upstream intron.
    Loh TJ, Cho S, Moon H, Jang HN, Williams DR, Jung DW, Kim IC, Ghigna C, Biamonti G, Zheng X, Shen H.
    Biochim Biophys Acta; 2015 Jun 15; 1849(6):743-50. PubMed ID: 25623890
    [Abstract] [Full Text] [Related]

  • 14. Downstream intronic splicing enhancers.
    Venables JP.
    FEBS Lett; 2007 Sep 04; 581(22):4127-31. PubMed ID: 17716673
    [Abstract] [Full Text] [Related]

  • 15. Coupling of signal transduction to alternative pre-mRNA splicing by a composite splice regulator.
    König H, Ponta H, Herrlich P.
    EMBO J; 1998 May 15; 17(10):2904-13. PubMed ID: 9582284
    [Abstract] [Full Text] [Related]

  • 16. A new alternatively spliced exon between v9 and v10 provides a molecular basis for synthesis of soluble CD44.
    Yu Q, Toole BP.
    J Biol Chem; 1996 Aug 23; 271(34):20603-7. PubMed ID: 8702806
    [Abstract] [Full Text] [Related]

  • 17. Exon-intron structure of a 2.7-kb transcript of the STM7 gene with phosphatidylinositol-4-phosphate 5-kinase activity.
    Pook MA, Carvajal JJ, Doudney K, Hillermann R, Chamberlain S.
    Genomics; 1997 May 15; 42(1):170-2. PubMed ID: 9177790
    [Abstract] [Full Text] [Related]

  • 18. Genome-wide detection and analysis of alternative splicing for nucleotide binding site-leucine-rich repeats sequences in rice.
    Gu L, Guo R.
    J Genet Genomics; 2007 Mar 15; 34(3):247-57. PubMed ID: 17498622
    [Abstract] [Full Text] [Related]

  • 19. A deep intronic mutation in FGB creates a consensus exonic splicing enhancer motif that results in afibrinogenemia caused by aberrant mRNA splicing, which can be corrected in vitro with antisense oligonucleotide treatment.
    Davis RL, Homer VM, George PM, Brennan SO.
    Hum Mutat; 2009 Feb 15; 30(2):221-7. PubMed ID: 18853456
    [Abstract] [Full Text] [Related]

  • 20. In vitro splicing analysis showed that availability of a cryptic splice site is not a determinant for alternative splicing patterns caused by +1G-->A mutations in introns of the dystrophin gene.
    Habara Y, Takeshima Y, Awano H, Okizuka Y, Zhang Z, Saiki K, Yagi M, Matsuo M.
    J Med Genet; 2009 Aug 15; 46(8):542-7. PubMed ID: 19001018
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.